Intl. Biotechnology Trust PLC
13 December 2007
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
1. Name of the issuer
International Biotechnology Trust plc
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in
accordance with section 324 (as extended by section 328) of the Companies Act
1985
Both (i) and (ii)
3. Name of person discharging managerial responsibility/director
Andrew Barker
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
Notification not in relation to a person connected to the Director named in 3
above
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
In respect of holding of Director referred to in 3 above
Beneficial interest
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
Ordinary shares of 25 pence each
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
Rock (Nominees) Limited
8. State the nature of the transaction
Purchase of Shares
9. Number of shares, debentures or financial instruments relating to shares
acquired
21,332 Ordinary Shares
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0302%
11. Number of shares, debentures or financial instruments relating to shares
disposed
Nil
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
133.75 pence per share
14. Date and place of transaction
12 December 2007 - London
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
160,000 Ordinary Shares, being 0.226% of the issuer's issued Ordinary share
capital
16. Date issuer informed of transaction
12 December 2007
17. Any additional information
None
18. Name of contact and telephone number for queries
Louise Richard - 020 7658 6501
Name and signature of duly authorised officer of issuer responsible for making
notification
Louise Richard
For and behalf of Schroder Investment Management Limited
Secretary to International Biotechnology Trust plc
Date of notification
13 December 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.